Document ID: chunk:federal_register_of_legislation:F2024C01137:reg:8a:p6
Version: federal_register_of_legislation:F2024C01137
Segment Type: reg
Provision Reference: reg 8A (pt 6/6)
Character Range: 59701–62601

GLEIF, the Reporting Entity must use all reasonable endeavours to report the LEI in a Reportable Transaction unless the OTC Derivative to which the LEI relates has been terminated or has expired; and
         1.        for a report about a Reportable Transaction that is the entry into, or assignment of an OTC Derivative or a change to the way a Reporting Entity records an OTC Derivative as specified in subrule 1.2.5(1)(b)(iv) and the entity to which the item relates is a natural person not eligible for the issue of an LEI per the ROC Statement, the Client Code;
         2.         for a report about a Reportable Transaction that is a modification or termination of an OTC Derivative or is a report made under rule 2.2.2, the identifier of the entity that was reported for the Reportable Transaction about which a report is being made; and
         3.        in this subrule, if the entity to which the item relates is comprised of two or more counterparties, other than a partnership, that entered into the Reportable Transaction as joint or joint and several counterparties, the entity is one of those joint or joint and several entities.
     (3) For a report made under Rule 2.2.2:
         1.         for the information that is being reported as changed, a Reporting Entity must report that information in accordance with the format and allowable values set out in columns 4-5 of the relevant tables;
         1.        for information other than entity identifiers that is being reported as not changed, a Reporting Entity must report that information in accordance with the format and allowable values set out in columns 4-5 of the relevant tables; and
         2.         for information about entity identifiers, a Reporting Entity may report that information in the format and value permitted by the Rules prior to 21 October 2024.
(4) A Small-scale Buy-side Entity is not required to report Derivative Transaction Information that is:
         1.         Items 10, 11 and 12 in Table S1.1(2); or
         2.        Items 13, 15, 16, 17, 20 and 21 in Table S1.1(3).

 Table S1.1(1): Transaction information
1. Item                                                                    2. Label                                         3. Derivative Transaction Information                                                                                                                                                                                                                                                                                                                                                                                                    4. Format                                                                                                                                                                 5. Allowable Values
Data elements related to UTI and UPI